It is less effective than other MAB anti-TNFi, but yet it is as effective (in RA AS and PsA) as all the others, but in Psoriasis and IBD its not as effective. Clearly there are differential mechanisms that are meaningful. Its not so clear that its related to apoptosis potential alone. JJC